HitGen LTD:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:HitGen LTD - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11216
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:33
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
HitGen LTD (HitGen) is a drug company that concentrates on hit identification and lead generation in the early phases of drug discoveries and development. The company provides OpenDEL, a collection of DNA encoded library compounds based on distinct, diverse and drug structures. It offers biological reagents, edge technology and services for progression of projects and services. HitGen provides services such as lead generation by DNA encoded chemical libraries; hit to lead expansion and lead optimization; custom compound and compound library synthesis and others. The company’s research support capabilities comprise protein expression and purification, chemical library design and synthesis, in-vitro screening and affinity selection, among others. It caters contract research organizations and pharmaceutical industries. HitGen is headquartered in Chengdu, China.

HitGen LTD – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
HitGen LTD, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
HitGen LTD, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
HitGen LTD, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
HitGen LTD, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
HitGen LTD, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
HitGen LTD, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
HitGen Raises USD39.1 Million in Series B Venture Financing 11
Partnerships 12
HitGen Enters into Research Agreement with LG Chem Life Sciences 12
HitGen Enters into Research Collaboration Agreement with Sanofi 13
HitGen Enters into Research Agreement with Boehringer Ingelheim 14
HitGen Enters into Agreement with Takeda Pharma 15
Cocrystal Pharma Enters into Research Agreement with HitGen and InterX 16
HitGen Enters into Agreement with Aduro Biotech 17
HitGen Enters into Research Agreement with LEO Pharma 18
HitGen Enters into Partnership with Scripps Research Institute and California Institute for Biomedical Research 19
HitGen Expands Agreement with Merck 20
HitGen Enters into Agreement with Janssen Biotech 21
HitGen Enters into Research Agreement with Global Blood Therapeutics 22
HitGen Enters into Drug Discovery Agreement with Cancer Research UK and Cancer Research Technology 23
HitGen Enters Into Distribution Agreement With Tecrea For HappyFect And NanoCargo 24
Licensing Agreements 25
Forma Therapeutics and HitGen Enter into Licensing Agreement 25
HitGen Enters into Licensing Agreement with Simcere Pharma 26
Pfizer Enters into Licensing Agreement with HitGen 27
Cancer Research UK and Cancer Research Technology Enter into Licensing Agreement with HitGen 28
HitGen LTD – Key Competitors 29
HitGen LTD – Key Employees 30
HitGen LTD – Locations And Subsidiaries 31
Head Office 31
Other Locations & Subsidiaries 31
Recent Developments 32
Government and Public Interest 32
Aug 03, 2018: HitGen launching initiative to discover new medicines to combat tuberculosis and malaria 32
Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33

List of Tables
HitGen LTD, Pharmaceuticals & Healthcare, Key Facts 2
HitGen LTD, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
HitGen LTD, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
HitGen LTD, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
HitGen LTD, Deals By Therapy Area, 2012 to YTD 2018 8
HitGen LTD, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
HitGen Raises USD39.1 Million in Series B Venture Financing 11
HitGen Enters into Research Agreement with LG Chem Life Sciences 12
HitGen Enters into Research Collaboration Agreement with Sanofi 13
HitGen Enters into Research Agreement with Boehringer Ingelheim 14
HitGen Enters into Agreement with Takeda Pharma 15
Cocrystal Pharma Enters into Research Agreement with HitGen and InterX 16
HitGen Enters into Agreement with Aduro Biotech 17
HitGen Enters into Research Agreement with LEO Pharma 18
HitGen Enters into Partnership with Scripps Research Institute and California Institute for Biomedical Research 19
HitGen Expands Agreement with Merck 20
HitGen Enters into Agreement with Janssen Biotech 21
HitGen Enters into Research Agreement with Global Blood Therapeutics 22
HitGen Enters into Drug Discovery Agreement with Cancer Research UK and Cancer Research Technology 23
HitGen Enters Into Distribution Agreement With Tecrea For HappyFect And NanoCargo 24
Forma Therapeutics and HitGen Enter into Licensing Agreement 25
HitGen Enters into Licensing Agreement with Simcere Pharma 26
Pfizer Enters into Licensing Agreement with HitGen 27
Cancer Research UK and Cancer Research Technology Enter into Licensing Agreement with HitGen 28
HitGen LTD, Key Competitors 29
HitGen LTD, Key Employees 30
HitGen LTD, Subsidiaries 31

List of Figures
HitGen LTD, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
HitGen LTD, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
HitGen LTD, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
HitGen LTD, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
HitGen LTD, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
HitGen LTD, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
HitGen LTD, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
HitGen LTD, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[HitGen LTD:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Applied Materials Inc (AMAT):企業の財務・戦略的SWOT分析
    Applied Materials Inc (AMAT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • ManTech International Corp (MANT):企業の財務・戦略的SWOT分析
    ManTech International Corp (MANT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Korea Electric Power Corp:企業の発電所・SWOT分析2018
    Korea Electric Power Corp - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key emp …
  • SRF Ltd (SRF):企業の財務・戦略的SWOT分析
    SRF Ltd (SRF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • PKO Bank Polski SA:企業の戦略・SWOT・財務情報
    PKO Bank Polski SA - Strategy, SWOT and Corporate Finance Report Summary PKO Bank Polski SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Euro India Fresh Foods, Ltd. (EIFFL):企業の財務・戦略的SWOT分析
    Euro India Fresh Foods, Ltd. (EIFFL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Monsanto Co (MON):製薬・医療:M&Aディール及び事業提携情報
    Summary Monsanto Company (Monsanto) is an agricultural products manufacturing company. It develops and delivers agricultural products to support farmers all around the world. The company develops biotechnology traits that assist farmers in controlling insects and weeds. It also provides other seed c …
  • Malee Group Public Company Limited:企業の戦略・SWOT・財務分析
    Malee Group Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary Malee Group Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • aap Implantate AG (AAQ):企業の製品パイプライン分析2018
    Summary aap Implantate AG (aap Implantate) is a medical device company, which develops, manufactures and markets trauma products and biomaterials for orthopedic treatment. Its products include locked plating systems for anatomical reduction, cannulated screws, standard plates and screws for osteosyn …
  • Jordan French Insurance Co. (P.L.C.):企業の戦略・SWOT・財務情報
    Jordan French Insurance Co. (P.L.C.) - Strategy, SWOT and Corporate Finance Report Summary Jordan French Insurance Co. (P.L.C.) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Oglethorpe Power Corporation:企業の発電所・SWOT分析2018
    Oglethorpe Power Corporation - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • RSA Insurance Group plc:企業のM&A・事業提携・投資動向
    RSA Insurance Group plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's RSA Insurance Group plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Bharat Dynamics Limited:企業の戦略・SWOT・財務情報
    Bharat Dynamics Limited - Strategy, SWOT and Corporate Finance Report Summary Bharat Dynamics Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Bassett Furniture Industries Inc (BSET):企業の財務・戦略的SWOT分析
    Bassett Furniture Industries Inc (BSET) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • E*Trade Financial Corporation:企業のM&A・事業提携・投資動向
    E*Trade Financial Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's E*Trade Financial Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • Qatar Airways Group Q.C.S.C.:企業の戦略・SWOT・財務情報
    Qatar Airways Group Q.C.S.C. - Strategy, SWOT and Corporate Finance Report Summary Qatar Airways Group Q.C.S.C. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Mitsui Mining & Smelting Co Ltd:企業の戦略・SWOT・財務分析
    Mitsui Mining & Smelting Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Mitsui Mining & Smelting Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Malayan Banking Berhad:企業のM&A・事業提携・投資動向
    Malayan Banking Berhad - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Malayan Banking Berhad Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Kennametal Inc.:企業の戦略・SWOT・財務分析
    Kennametal Inc. - Strategy, SWOT and Corporate Finance Report Summary Kennametal Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • InSightec Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Insightec Ltd (InSightec), a subsidiary of Elbit Imaging Ltd, is a medical device company that develops and markets magnetic resonance imaging ultrasound based medical devices. The company offers products through divisions such as neurosurgery, urology, oncology and womens’ health. Its servi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆